| Income Statement |
| Total Revenue | 308.21M |
|
| Revenues (USD) | 308.21M |
| Gross Profit | 308.21M |
| Operating Expenses | 315.73M |
| Research and Development Expense | 80.11M |
| Selling, General and Administrative Expense | 180.53M |
| Operating Income | -7.52M |
| Income Tax Expense | 84.00K |
| Net Income | -6.65M |
| Net Income Common Stock | -6.65M |
| Net Income Common Stock (USD) | -6.65M |
| Consolidated Income | -6.65M |
| Earnings per Basic Share | -0.07 |
| Earnings per Basic Share (USD) | -0.07 |
| Earnings per Diluted Share | -0.07 |
| Earning Before Interest & Taxes (EBIT) | -6.56M |
| Earning Before Interest & Taxes (USD) | -6.56M |
| Weighted Average Shares | 96.90M |
| Weighted Average Shares Diluted | 96.90M |
| Balance Sheet |
| Cash and Equivalents | 931.33M |
| Cash and Equivalents (USD) | 931.33M |
| Investments | 1.75B |
| Property, Plant & Equipment Net | 61.61M |
| Total Assets | 2.96B |
| Total Debt | 1.98B |
| Total Liabilities | 2.23B |
| Accumulated Retained Earnings (Deficit) | -364.20M |
| Shareholders Equity | 733.17M |
| Shareholders Equity (USD) | 733.17M |
| Total Debt (USD) | 1.98B |
| Goodwill and Intangible Assets | 67.06M |
| Trade and Non-Trade Payables | 125.52M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.86M |
| Net Cash Flow from Financing | 6.74M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -125.68M |
| Capital Expenditure | -6.99M |
| Issuance (Purchase) of Equity Shares | -94.80M |
| Issuance (Repayment) of Debt Securities | 83.68M |
| Net Cash Flow from Investing | 876.00K |
| Net Cash Flow - Investment Acquisitions and Disposals | 7.87M |
| Net Cash Flow from Operations | -133.30M |
| Share Based Compensation | 34.81M |